Clinical Trials Logo

Sleep Architecture clinical trials

View clinical trials related to Sleep Architecture.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05466864 Recruiting - Stroke, Acute Clinical Trials

Screening of OSA in Hospitalized Stroke Patients Using BSP

Start date: May 4, 2022
Phase: N/A
Study type: Interventional

Obstructive sleep apnea (OSA) is prevalent in patients with stroke and has a negative effect on outcomes by predisposing them to recurrent stroke, increasing mortality, and so forth. Therefore, it is extremely important to identify OSA in patients with stroke. Wearable devices can greatly reduce the manpower and material requirements of traditional laboratory-based polysomnography (PSG). With Photoplethysmography (PPG) technology and neural network algorithms, the Belun ring and the sleeping platform not only can detect blood oxygen, and heart rate but also can identify sleep stage and estimate the severity of sleep apnea. In this study, inpatients with acute ischemic stroke in the hospital will proceed with three nights test for recording the parameters of the autonomic nervous system in the acute phase, evaluate whether sleep apnea and the feasibility of the Belun sleep platform. It is important that early recognition of OSA and prompt treatment, which can potentially improve OSA-associated adverse outcomes, as well as understanding the degree of autonomic nervous function impairment for patients with acute ischemic stroke. After smoothing this process, it can help clinicians more accurately comprehend the condition, timing of admission, and discharge.

NCT ID: NCT04885062 Recruiting - Clinical trials for Sleep-Disordered Breathing

Belun Ring Platform With an Improved Algorithm for OSA Assessment

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

OSA is commonly diagnosed with either attended in-lab polysomnography (PSG) or unattended home sleep apnea testing (HSAT). The BLS-100 (Belun Technology Company Limited, Hong Kong) is a novel neural network-based HSAT platform consists of a ring shape pulse oximeter sensor, a cradle, and an improved proprietary analytic algorithm. This study investigates the hypothesis that the BLS-100 is a reasonable HSAT device for OSA assessment.